Abstract:Over the last few decades, stem cell-based therapy has become a novel strategy for a variety of disorders including cardiovascular, digestive and respiratory diseases. Among the stem cells investigated, mesenchymal stem cells (MSCs) are the ideal candidate cell source due to their many characteristics, including ease of isolation and expansion, multilineage differentiation potential and immunoregulatory function. Nevertheless MSCs derived from aged donors or patients with agerelated diseases are senescent (Shi et al., 2021). In addition, prolonged in vitro expansion induces MSC senescence (Li et al., 2019). Although allogeneic transplantation of MSCs exerts beneficial effects in the early days post-transplantation, long-term benefits compared with those of autologous MSCs are compromised due to sustained immunorejection (Huang et al., 2010). Senescence severely affects the characteristics and function of MSCs, limiting their application in regenerative medicine. Exploring effective strategies to rejuvenate autologous senescent MSC and improve their therapeutic capacity is vital. Although multiple factors including age, oxidative stress and mitochondrial dysfunction have been reported to mediate MSC senescence, the underlying mechanisms of this senescence remain unclear. There are twelve manuscripts in this Research Topic, highlighting the current understanding of the potential mechanisms underlying MSC senescence and novel strategies to rejuvenate the senescent MSC. Liu et al. and Zhou et al. summarize the current knowledge of phenotypic and biological properties of senescent MSCs and strategies for monitoring and rejuvenation, including gene modification and pretreatment strategies (Liu et al.; Zhou et al.). They also systematically review the molecular mechanisms underlying MSC senescence including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. There is accumulating evidence that autophagy acts as a positive and negative regulator of MSC senescence (Ma et al., 2018; Yang et al., 2018). Rastaldo et al. discuss these conflicting roles of autophagy in MSC senescence and potential mechanistic explanations for such an intricate liaison (Rastaldo et al.). Sirtuin 3 (SIRT3), an NAD + -dependent deacetylase, regulates a variety of physiological and pathological processes including aging and aging-related diseases. Ma et al. have shown that reduced Sirt3 expression contributes to age-related natural senescence and H2O2-induced premature senescence of rat bone marrow (BM)-MSCs by stimulating cellular reactive oxygen species (ROS) production and DNA injury (Ma et al.). Overexpressing Sirt3 partly reversed the senescence-associated phenotypic features of natural and premature senescent MSCs by alleviating ROS generation and upregulating SOD2 expression. Qin et al. reveal that knockout of NO synthase 2 significantly promoted the adipogenic, but not osteogenic, differentiation capacity of rat MSCs (Qin et al.). Notably, they also showed that knockout of NOS2 in MSCs resulted in significant obesity in rat fed a high-fat diet. Edited by: Atsushi Asakura, University of Minnesota Twin Cities, United States

Mesenchymal stem cells from adipose tissue prone to lose their stemness associated markers in obesity related stress conditions

Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells.

Aging alters tissue resident mesenchymal stem cell properties

Effects of Obesity on Reparative Function of Human Adipose Tissue-Derived Mesenchymal Stem Cells on Ischemic Murine Kidneys

Impaired immunomodulatory capacity in adipose tissue‐derived mesenchymal stem/stromal cells isolated from obese patients

Obesity-driven mitochondrial dysfunction in human adipose tissue-derived mesenchymal stem/stromal cells involves epigenetic changes

Declined adipogenic potential of senescent MSCs due to shift in insulin signaling and altered exosome cargo

Effects of high glucose and severe hypoxia on the biological behavior of mesenchymal stem cells at various passages

Diabetic microenvironment deteriorates the regenerative capacities of adipose mesenchymal stromal cells

Obesity-induced Mitochondrial Dysfunction in Porcine Adipose Tissue-Derived Mesenchymal Stem Cells

Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Editorial: Mesenchymal Stem Cell Senescence and Rejuvenation

Anti-obesity Effect and Mechanism of Mesenchymal Stem Cells Influence on Obese Mice.

Senescence-Associated Alterations in Matrisome of Mesenchymal Stem Cells

Oxidative stress and regulation of adipogenic differentiation capacity by sirtuins in adipose stem cells derived from female patients of advancing age

The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice

Human adipose-derived mesenchymal stromal cells from face and abdomen undergo replicative senescence and loss of genetic integrity after long-term culture

Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting

Adipose tissue place of origin and obesity influence sphingolipid signaling pathway in the adipocytes differentiated from ADMSCs isolated from morbidly obese women

Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity